Hamberg O
Medical dept. F, Glostrup University Hospital.
Dan Med Bull. 1997 Jun;44(3):225-41.
Diet protein increases whereas carbohydrates decrease urea synthesis. Traditionally, these effects have been explained by changes in substrate supply. Diet protein intake increases whereas carbohydrate decreases blood amino acid concentration. However, glucose also decreases urea synthesis by a hepatic mechanism independent of the decrease in blood amino acid concentration. Whether this is due to an effect of glucose in itself, or whether the fall in glucagon or the rise in insulin is responsible, was not known. This survey deals with the effect of an increase in diet protein intake and of the separate effects of glucose, glucagon and insulin on functional hepatic nitrogen clearance in normal man and in patients with cirrhosis of the liver. The functional hepatic nitrogen clearance is calculated as the slope of the linear regression analysis of alanine-stimulated urea synthesis rate and blood alpha-amino nitrogen concentration, and expresses urea synthesis independent of changes in blood amino acid concentration. In patients with cirrhosis, hepatic nitrogen clearance is reduced in parallel with liver cell mass, despite high glucagon concentration that would normally up-regulate the process. In both healthy subjects and in patients with cirrhosis, an increase in diet protein intake (plus approximately 50 g/day) for 14 days increases hepatic nitrogen clearance by 40%. Thus, in addition to the substrate effect, protein intake increases urea synthesis by an effect in the liver, probably by enzyme formation. What induces this is not clear but high postprandial levels of glucagon may be involved. Although the effect is qualitatively intact in the patients, the response relative to the increase in protein intake is reduced by two-thirds. The effect may be important to control blood amino acid concentration during a high protein diet and may partly explain why patients with cirrhosis usually tolerates protein hyperalimentation without developing hepatic encephalopathy. It is shown that the reduction of hepatic nitrogen clearance by glucose depends on hyperglycaemia, and is accomplished by the additive effects of a direct hormone-independent action of glucose, and indirectly via suppression of glucagon. Insulin is not a direct controller of hepatic nitrogen clearance, but is still considered an important regulator of urea synthesis by its reducing effects on blood amino acid concentration. High experimental glucagon levels overrule the normal suppressive effect of glucose. In contrast, it is shown that the sugar-alcohol xylitol normalises the glucagon induced increase in hepatic nitrogen clearance. During normal glucagon levels xylitol exerts only a very little decrease in hepatic nitrogen clearance. In patients with cirrhosis, glucose does not down-regulate hepatic nitrogen clearance. However, when the spontaneous high glucagon levels are normalised by somatostatin, glucose decreases hepatic nitrogen clearance. This shows that the direct hormone-independent effect of glucose is intact. These findings indicate that the high glucagon levels during spontaneous hormone responses overrule the suppressive effect of glucose. Incomplete glucose suppression of glucagon secretion during alanine infusion contributes to the high glucagon levels. The removal of the high glucagon levels decreases hepatic nitrogen clearance in itself. Thus, the hyperglucagonaemia may be a compensatory mechanism by which the cirrhotic liver to some extent reestablishes its capacity to produce urea. The consequence is the defective down-regulation of hepatic nitrogen clearance by glucose. The reduction in urea synthesis by glucose, i.e. its nitrogen sparing effect, is accomplished by two different mechanisms: A hepatic component (reduction of the hepatic nitrogen clearance) and a peripheral component (reduced substrate availability mediated by the insulin response). This is an extension of former thoughts according to which glucose reduces urea synthesis due solely to
膳食蛋白质可增加而碳水化合物可减少尿素合成。传统上,这些效应是通过底物供应的变化来解释的。膳食蛋白质摄入量增加而碳水化合物摄入量减少会降低血液氨基酸浓度。然而,葡萄糖也通过一种独立于血液氨基酸浓度降低的肝脏机制来减少尿素合成。这是由于葡萄糖本身的作用,还是由于胰高血糖素的下降或胰岛素的上升所致,尚不清楚。本研究探讨了膳食蛋白质摄入量增加以及葡萄糖、胰高血糖素和胰岛素分别对正常人和肝硬化患者肝脏功能性氮清除率的影响。肝脏功能性氮清除率通过丙氨酸刺激的尿素合成速率与血液α-氨基氮浓度的线性回归分析斜率来计算,并表示独立于血液氨基酸浓度变化的尿素合成情况。在肝硬化患者中,尽管胰高血糖素浓度通常会上调该过程,但肝脏氮清除率与肝细胞数量平行降低。在健康受试者和肝硬化患者中,14天内膳食蛋白质摄入量增加(约增加50克/天)可使肝脏氮清除率提高40%。因此,除了底物效应外,蛋白质摄入还通过肝脏中的作用,可能是通过酶的形成来增加尿素合成。其诱导因素尚不清楚,但餐后高胰高血糖素水平可能与之有关。尽管在患者中该效应在性质上是完整的,但相对于蛋白质摄入量增加的反应降低了三分之二。该效应对于控制高蛋白饮食期间的血液氨基酸浓度可能很重要,并且可以部分解释为什么肝硬化患者通常能够耐受蛋白质超量营养而不发生肝性脑病。研究表明,葡萄糖对肝脏氮清除率的降低取决于高血糖症,并且是通过葡萄糖直接的非激素依赖性作用以及通过抑制胰高血糖素的间接作用共同实现的。胰岛素不是肝脏氮清除率的直接调节因子,但仍被认为是通过降低血液氨基酸浓度而对尿素合成具有重要调节作用。实验性高胰高血糖素水平会抵消葡萄糖的正常抑制作用。相反,研究表明糖醇木糖醇可使胰高血糖素诱导的肝脏氮清除率增加恢复正常。在正常胰高血糖素水平下,木糖醇仅使肝脏氮清除率略有降低。在肝硬化患者中,葡萄糖不会下调肝脏氮清除率。然而,当通过生长抑素使自发的高胰高血糖素水平恢复正常时,葡萄糖会降低肝脏氮清除率。这表明葡萄糖直接的非激素依赖性作用是完整的。这些发现表明,自发激素反应期间的高胰高血糖素水平会抵消葡萄糖的抑制作用。丙氨酸输注期间葡萄糖对胰高血糖素分泌的抑制不完全导致了高胰高血糖素水平。去除高胰高血糖素水平本身会降低肝脏氮清除率。因此,高胰高血糖素血症可能是一种代偿机制,通过该机制肝硬化肝脏在一定程度上重新建立其产生尿素的能力。结果是葡萄糖对肝脏氮清除率的下调存在缺陷。葡萄糖对尿素合成的降低,即其氮节约效应,是通过两种不同机制实现的:肝脏成分(肝脏氮清除率降低)和外周成分(由胰岛素反应介导的底物可用性降低)。这是对以前观点的扩展,即以前认为葡萄糖降低尿素合成仅仅是由于……